The EMA has recommended label expansions for Inaqovi, Opdivo, and Venclyxto, broadening treatment options in AML, Hodgkin lymphoma, and CLL.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-broadens-use-targeted-combinations-blood-cancers-2026a1000dca?src=rss
Author :
Publish date : 2026-04-27 14:32:00
Copyright for syndicated content belongs to the linked Source.
